Jiangxi Synergy Pharmaceutical Co., Ltd. (SHE:300636)

SHE:300636 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Operating Revenue	738.38	757.93	720.7	718.59	589.07	433.97
Other Revenue	0.96	0.96	1.43	1.32	3.06	1.45
Revenue	739.33	758.89	722.14	719.91	592.13	435.42
Revenue Growth (YoY)	4.45%	5.09%	0.31%	21.58%	35.99%	5.41%
Cost of Revenue	543.97	539.38	501.78	493.84	420.85	285.43
Gross Profit	195.36	219.51	220.36	226.07	171.28	149.99
Selling, General & Admin	64	63.78	59.85	51.33	39.01	31.02
Research & Development	63.3	59.45	63.15	60.91	39.02	35.3
Other Operating Expenses	6.35	5.35	3.62	2.39	1.82	1.5
Operating Expenses	132.8	129.84	126.51	116.11	81.96	65.2
Operating Income	62.56	89.67	93.85	109.95	89.32	84.79
Interest Expense	-17.07	-18.14	-9.9	-7.7	-5.69	-8.99
Interest & Investment Income	28.71	30.8	17.58	2.89	1.97	0.64
Currency Exchange Gain (Loss)	5.84	5.84	3.03	-2.13	0.85	-1.31
Other Non Operating Income (Expenses)	-0.85	-0.99	-0.75	-0.75	-0.42	-0.34
EBT Excluding Unusual Items	79.2	107.17	103.81	102.27	86.02	74.79
Gain (Loss) on Sale of Investments	-0.02	0.05	-	-1.21	0.26	-
Gain (Loss) on Sale of Assets	-1.27	-1.17	-1.32	-0.18	-1.01	-1.73
Other Unusual Items	8.64	8.64	10.01	5.27	3.07	5
Pretax Income	87.77	114.69	112.5	106.15	88.34	78.06
Income Tax Expense	3.97	8.11	6.52	5.48	7.22	8.01
Net Income	83.8	106.58	105.98	100.67	81.12	70.05
Net Income to Common	83.8	106.58	105.98	100.67	81.12	70.05
Net Income Growth	-28.04%	0.57%	5.28%	24.10%	15.80%	45.01%
Shares Outstanding (Basic)	420	420	380	326	309	309
Shares Outstanding (Diluted)	420	420	380	346	338	310
Shares Change (YoY)	5.53%	10.39%	9.89%	2.55%	9.05%	-0.43%
EPS (Basic)	0.20	0.25	0.28	0.31	0.26	0.23
EPS (Diluted)	0.20	0.25	0.28	0.29	0.24	0.23
EPS Growth	-31.81%	-8.90%	-4.20%	21.02%	6.19%	45.62%
Free Cash Flow	116.96	148.7	-50.9	-115.5	-293.33	-149.93
Free Cash Flow Per Share	0.28	0.35	-0.13	-0.33	-0.87	-0.48
Dividend Per Share	0.040	0.040	0.040	0.045	0.040	0.035
Dividend Growth	-	-	-11.11%	12.50%	12.99%	0.57%
Gross Margin	26.42%	28.93%	30.51%	31.40%	28.93%	34.45%
Operating Margin	8.46%	11.82%	13.00%	15.27%	15.09%	19.47%
Profit Margin	11.34%	14.04%	14.68%	13.98%	13.70%	16.09%
Free Cash Flow Margin	15.82%	19.59%	-7.05%	-16.04%	-49.54%	-34.43%
EBITDA	187.59	203.4	162.39	175.99	140.34	137.12
EBITDA Margin	25.37%	26.80%	22.49%	24.45%	23.70%	31.49%
D&A For EBITDA	125.03	113.73	68.55	66.04	51.02	52.33
EBIT	62.56	89.67	93.85	109.95	89.32	84.79
EBIT Margin	8.46%	11.82%	13.00%	15.27%	15.09%	19.47%
Effective Tax Rate	4.52%	7.07%	5.79%	5.17%	8.17%	10.26%
Revenue as Reported	739.33	758.89	722.14	719.91	592.13	435.42
Advertising Expenses	-	3.08	2.35	0.19	0.62	1.09

Source: S&P Global Market Intelligence. Standard template. Financial Sources.